{"organizations": [], "uuid": "be154928eb991dc4058a5cf48d2b399a66955100", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180411.html", "section_title": "Archive News &amp; Video for Wednesday, 11 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-theraclion-accelerates-its-sales-a/brief-theraclion-accelerates-its-sales-and-clinical-development-in-asia-idUSFWN1RO0SZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Theraclion Accelerates Its Sales And Clinical Development In Asia", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.997, "site_type": "news", "published": "2018-04-12T00:28:00.000+03:00", "replies_count": 0, "uuid": "be154928eb991dc4058a5cf48d2b399a66955100"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-theraclion-accelerates-its-sales-a/brief-theraclion-accelerates-its-sales-and-clinical-development-in-asia-idUSFWN1RO0SZ", "ord_in_thread": 0, "title": "BRIEF-Theraclion Accelerates Its Sales And Clinical Development In Asia", "locations": [], "entities": {"persons": [{"name": "theraclion", "sentiment": "negative"}], "locations": [{"name": "asia", "sentiment": "none"}, {"name": "taiwan", "sentiment": "none"}, {"name": "singapore", "sentiment": "none"}, {"name": "south korea", "sentiment": "none"}, {"name": "hong kong", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sia", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 11 (Reuters) - THERACLION SA:\n* THERACLION ACCELERATES ITS SALES AND CLINICAL DEVELOPMENT IN ASIA\n* ECHOTHERAPY IS NOW PROPOSED IN ROUTINE CLINICAL TREATMENT IN 4 SITES IN HONG KONG AND ONE IN SINGAPORE\n* APPROVAL BY THE TAIWAN HEALTH AUTHORITIES OF ECHOPULSE IN THE TREATMENT OF BREAST FIBROADENOMA\n* ECHOPULSE: FURTHER AUTHORIZATION EVALUATIONS ARE IN PROCESS IN SOUTH KOREA AND TAIWAN (THYROID) Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-12T00:28:00.000+03:00", "crawled": "2018-04-12T14:12:26.014+03:00", "highlightTitle": ""}